Stock Plans (Tables)

12 Months Ended

Dec. 31, 2019

Stock Plans [Abstract]

Summary of Weighted-Average Fair-Value and Vesting of Restricted Stock Grants

	2019				2018				2017
			Weighted-				Weighted-				Weighted-
			average				average				average
	Shares		grant date		Shares		grant date		Shares		grant date
	granted		fair value		granted		fair value		granted		fair value
Director plan	5,600	(3)	$	54.69	8,400	(3)	$	49.50	8,400	(2)	$	26.17
Omnibus plan	7,251	(3)		54.69	10,800	(3)		45.83	4,749	(3)		23.93
Omnibus plan	50	(1)		58.08	50	(1)		49.50	75	(1)		26.17
Total	12,901		$	54.70	19,250		$	47.44	13,224		$	25.36

⁽¹⁾ Vest after 1 year  (2) Vest over 2 years –50%  each year  (3) Vest over 3 years – 33% each year 

Schedule of Non-Vested Restricted Stock Units Activity

	2012 Stock incentive plans
	Director	Omnibus	Total		Weighted- average grant date fair value
Non-vested balance at December 31, 2016	8,400	13,562	21,962	$	20.31
Granted	8,400	4,824	13,224		25.36
Forfeited	-	-	-
Vested	(8,400)	(6,082)	(14,482)		20.47
Non-vested balance at December 31, 2017	8,400	12,304	20,704	$	23.59
Granted	8,400	10,850	19,250		47.44
Forfeited	-	-	-
Vested	(4,200)	(5,794)	(9,994)		23.69
Non-vested balance at December 31, 2018	12,600	17,360	29,960	$	38.99
Granted	5,600	7,301	12,901		54.70
Forfeited	-	(126)	(126)		54.69
Vested	(7,000)	(8,574)	(15,574)		33.81
Non-vested balance at December 31, 2019	11,200	15,961	27,161	$	49.48

Schedule of SSARs Activity

	Awards		Weighted-average grant date fair value	Weighted-average remaining contractual term (years)
Outstanding December 31, 2016	29,014	$	3.48	9.1
Granted	24,346		5.06	10.0
Exercised	-		-
Forfeited	-		-
Outstanding December 31, 2017	53,360	$	4.20	8.5
Granted	38,941		13.73	10.0
Exercised	(3,051)		4.03
Forfeited	-		-
Outstanding December 31, 2018	89,250	$	8.36	8.2
Granted	11,073		16.79	10.0
Exercised	(3,059)		3.48
Forfeited	-		-
Outstanding December 31, 2019	97,264	$	9.47	7.5

Of the SSARs outstanding at December 31, 2019, 52,112 vested and were exercisable. SSARs vest over a three year period – 33% per year.

Schedule of Compensation Cost for Share-Based Payment Arrangements, Allocation of Share-Based Compensation Costs by Plan

(dollars in thousands)	2019		2018		2017
Stock-based compensation expense:
Director stock incentive plan	$	240	$	237	$	116
Omnibus stock incentive plan		611		500		194
Employee stock purchase plan		107		143		23
Total stock-based compensation expense	$	958	$	880	$	333

In addition, during 2019, 2018 and 2017 the Company reversed accruals of ($0.1 million), ($0.1 million) and accrued $0.2 million in stock-based compensation expense for restricted stock and SSARs to be awarded under the Omnibus Plan. 

Schedule of Unrecognized Compensation Cost, Non-Vested Awards

	As of
(dollars in thousands)	December 31, 2019
Unrecognized stock-based compensation expense:
Director plan	$	364
Omnibus plan		781
Total unrecognized stock-based compensation expense	$	1,145

The unrecognized stock-based compensation expense as of December 31, 2019 will be recognized ratably over the periods ended January 2022 and January 2022 for the Director Plan and the Omnibus Plan, respectively.

Summary Of Stock Option Activity

	Options		Weighted-average exercise price	Weighted-average remaining contractual term (years)
Outstanding and exercisable, December 31, 2016	22,500	$	19.12	1.0
Granted	-		-
Exercised	(21,750)		19.14
Forfeited	-		-
Outstanding and exercisable, December 31, 2017	750	$	18.50	0.2
Granted	-		-
Exercised	(750)		18.50
Forfeited	-		-
Outstanding and exercisable, December 31, 2018	-	$	-	-